The proton exchange membrane (PEM) water electrolysis is one of the most promising hydrogen production techniques. The oxygen evolution reaction (OER) occurring at the anode dominates the overall ...efficiency. Developing active and robust electrocatalysts for OER in acid is a longstanding challenge for PEM water electrolyzers. Most catalysts show unsatisfied stability under strong acidic and oxidative conditions. Such a stability challenge also leads to difficulties for a better understanding of mechanisms. This review aims to provide the current progress on understanding of OER mechanisms in acid, analyze the promising strategies to enhance both activity and stability, and summarize the state‐of‐the‐art catalysts for OER in acid. First, the prevailing OER mechanisms are reviewed to establish the physicochemical structure–activity relationships for guiding the design of highly efficient OER electrocatalysts in acid with stable performance. The reported approaches to improve the activity, from macroview to microview, are then discussed. To analyze the problem of instability, the key factors affecting catalyst stability are summarized and the surface reconstruction is discussed. Various noble‐metal‐based OER catalysts and the current progress of non‐noble‐metal‐based catalysts are reviewed. Finally, the challenges and perspectives for the development of active and robust OER catalysts in acid are discussed.
Developing proton exchange membrane water electrolyzers requires a fundamental understanding of the oxygen evolution reaction (OER) in acid, which is the primary focus of this review. The water electrolyzer in alkaline and acid are compared; and the recent advances in OER mechanisms, the strategies for enhancing activity and stability of electrocatalysts, surface reconstruction, and the state‐of‐the‐art electrocatalysts are discussed.
Full text
Available for:
BFBNIB, FZAB, GIS, IJS, KILJ, NLZOH, NUK, OILJ, SAZU, SBCE, SBMB, UL, UM, UPUK
Owing to the unique electronic properties, rare‐earth modulations in noble‐metal electrocatalysts emerge as a critical strategy for a broad range of renewable energy solutions such as water‐splitting ...and metal–air batteries. Beyond the typical doping strategy that suffers from synthesis difficulties and concentration limitations, the innovative introduction of rare‐earth is highly desired. Herein, a novel synthesis strategy is presented by introducing CeO2 support for the nickel–iron–chromium hydroxide (NFC) to boost the oxygen evolution reaction (OER) performance, which achieves an ultralow overpotential at 10 mA cm−2 of 230.8 mV, the Tafel slope of 32.7 mV dec−1, as well as the excellent durability in alkaline solution. Density functional theory calculations prove the established d–f electronic ladders, by the interaction between NFC and CeO2, evidently boosts the high‐speed electron transfer. Meanwhile, the stable valence state in CeO2 preserves the high electronic reactivity for OER. This work demonstrates a promising approach in fabricating a nonprecious OER electrocatalyst with the facilitation of rare‐earth oxides to reach both excellent activity and high stability.
A novel and highly efficient hybrid electrocatalyst is synthesized by NiFeCr hydroxide deposited on a porous peapod‐like Cu@CeO2 nanotube array. The introduction of CeO2 supplies abundant d–f orbital ladders to construct a highly efficient electron transfer expressway, leading to superior alkaline oxygen evolution reaction performance.
Full text
Available for:
BFBNIB, FZAB, GIS, IJS, KILJ, NLZOH, NUK, OILJ, SAZU, SBCE, SBMB, UL, UM, UPUK
Oxidative stress and cardiomyocyte apoptosis play critical roles in doxorubicin (DOX)-induced cardiotoxicity. Previous studies indicated that fibronectin type III domain-containing 5 (FNDC5) and its ...cleaved form, irisin, could preserve mitochondrial function and attenuate oxidative damage as well as cell apoptosis, however, its role in DOX-induced cardiotoxicity remains unknown. Our present study aimed to investigate the role and underlying mechanism of FNDC5 on oxidative stress and cardiomyocyte apoptosis in DOX-induced cardiotoxicity. Cardiomyocyte-specific FNDC5 overexpression was achieved using an adeno-associated virus system, and then the mice were exposed to a single intraperitoneal injection of DOX (15 mg/kg) to generate DOX-induced cardiotoxicity. Herein, we found that FNDC5 expression was downregulated in DOX-treated murine hearts and cardiomyocytes. Fndc5 deficiency resulted in increased oxidative damage and apoptosis in H9C2 cells under basal conditions, imitating the phenotype of DOX-induced cardiomyopathy in vitro, conversely, FNDC5 overexpression or irisin treatment alleviated DOX-induced oxidative stress and cardiomyocyte apoptosis in vivo and in vitro. Mechanistically, we identified that FNDC5/Irisin activated AKT/mTOR signaling and decreased DOX-induced cardiomyocyte apoptosis, and moreover, we provided direct evidence that the anti-oxidant effect of FNDC5/Irisin was mediated by the AKT/GSK3β/FYN/Nrf2 axis in an mTOR-independent manner. And we also demonstrated that heat shock protein 20 was responsible for the activation of AKT caused by FNDC5/Irisin. In line with the data in acute model, we also found that FNDC5/Irisin exerted beneficial effects in chronic model of DOX-induced cardiotoxicity (5 mg/kg, i.p., once a week for three times, the total cumulative dose is 15 mg/kg) in mice. Based on these findings, we supposed that FNDC5/Irisin was a potential therapeutic agent against DOX-induced cardiotoxicity.
Full text
Available for:
EMUNI, FIS, FZAB, GEOZS, GIS, IJS, IMTLJ, KILJ, KISLJ, MFDPS, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, SBMB, SBNM, UKNU, UL, UM, UPUK, VKSCE, ZAGLJ
Assembly of micro-/nanocapsules holds great potential for catalysis, storage, and drug delivery due to their modifiable shell, high exposed surface area, and large accommodation space. Here, an ...ingenious one-step reaction strategy is presented to fabricate layered double hydroxide (LDH) microcapsules, which benefit from the oxyphilic and synergistic coordination of Ce species to stabilize the initial morphology of metal-organic frameworks (MOFs). Taking advantage of this unique superstructure, the as-prepared Ni-Fe-Ce-LDH microcapsules demonstrate excellent oxygen evolution reaction (OER) activity with an overpotential of 242 mV at 10 mA cm
−2
and long-term durability of at least 24 h. Density functional theory (DFT) results further confirm the electronic modulation induced by the Ce doping for both subtle 3D LDH architectures and superior OER performances. This work not only provides insight into the rare-earth (RE) doping mediated crystal growth and transformation process of MOFs but also represents a facile way to fabricate the desired microcapsule superstructure by virtue of the Lewis acid property and synergistic coordination of RE-ions.
A one-step synthesis has been developed to fabricate layered double hydroxide microcapsules
via
a Ce-doping strategy in metal-organic frameworks.
Anti‐counterfeiting techniques have become a global topic since they is correlated to the information and data safety, in which multimodal luminescence is one of the most desirable candidates for ...practical applications. However, it is a long‐standing challenge to actualize robust multimodal luminescence with high thermal stability and humid resistance. Conventionally, the multimodal luminescence is usually achieved by the combination of upconversion and downshifting luminescence, which only responds to the electromagnetic waves in a limited range. Herein, the Yb3+/Er3+/Bi3+ co‐doped Cs2Ag0.6Na0.4InCl6 perovskite material is reported as an efficient multimodal luminescence material. Beyond the excitation of ultraviolet light and near‐infrared laser (980 nm), this work extends multimodal luminescence to the excitation of X‐ray. Besides the flexible excitation sources, this material also shows the exceptional luminescence performance, in which the X‐ray detection limit reaches the level of nGy s−1, indicating a great potential for further application as a colorless pigment in the anti‐counterfeiting field. More importantly, the obtained double perovskite features high stability against both humidity and temperature up to 400 °C. This integrated multifunctional luminescent material provides a new directional solution for the development of multifunctional optical materials and devices.
A Yb3+/Er3+/Bi3+ co‐doped Cs2Ag0.6Na0.4InCl6 double‐perovskite material shows multi‐modal luminescence under excitation by X‐rays, ultraviolet light, and near‐infrared laser light (980 nm), which also features high stability against humidity and high temperature (up to 400 °C). This luminescent material further extends the functionality and potential for future commercial applications in anti‐counterfeiting and X‐ray detection.
Full text
Available for:
BFBNIB, FZAB, GIS, IJS, KILJ, NLZOH, NUK, OILJ, SAZU, SBCE, SBMB, UL, UM, UPUK
•This paper provides a comprehensive review of FMEA using MCDM methods.•The 169 articles were found and classified according to the used MCDM methods.•The risk factors, risk factor weighting methods ...and risk assessment methods are analyzed.•Directions for future research to adopt MCDM methods for FMEA are provided.
Failure mode and effect analysis (FMEA) is a proactive reliability management technique extensively utilized in a variety of fields. To enhance the effectiveness of FMEA, a great many multi-criteria decision making (MCDM) methods have been applied for properly evaluating the risk of failure modes over the past two decades. However, there is a lack of study concerning systematic literature review and classification of the researches on this topic. This article aims to provide a comprehensive review of the FMEA studies using MCDM approaches for evaluation and prioritization of failure modes. To do so, a total of 169 journal papers extracted from the online database over the period of 1998–2018 were selected and reviewed. These publications were classified into 10 categories according to the used MCDM methods, and analyzed in regard to the risk factors, risk factor weighting methods, and risk assessment methods in FMEA. Furthermore, a bibliometric analysis was performed based on the frequency of MCDM methods, number of citations, year of publication, appeared journals, country of origin and application areas. This research supports academics and practitioners in effectively adopting MCDM methods to overcome the deficiencies of the traditional FMEA and provides an insight into its state-of-the-art.
Full text
Available for:
GEOZS, IJS, IMTLJ, KILJ, KISLJ, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UILJ, UL, UM, UPUK, ZAGLJ, ZRSKP
Objective
Despite the increasing number of genes associated with Charcot–Marie‐Tooth (CMT) disease, many patients currently still lack appropriate genetic diagnosis for this disease. Autosomal ...dominant mutations in aminoacyl‐tRNA synthetases (ARSs) have been implicated in CMT. Here, we describe causal missense mutations in the gene encoding seryl‐tRNA synthetase 1 (SerRS) for 3 families affected with CMT.
Methods
Whole‐exome sequencing was performed in 16 patients and 14 unaffected members of 3 unrelated families. The functional impact of the genetic variants identified was investigated using bioinformatic prediction tools and confirmed using cellular and biochemical assays.
Results
Combined linkage analysis for the 3 families revealed significant linkage (Zmax LOD = 6.9) between the genomic co‐ordinates on chromosome 1: 108681600–110300504. Within the linkage region, heterozygous SerRS missense variants segregated with the clinical phenotype in the 3 families. The mutant SerRS proteins exhibited reduced aminoacylation activity and abnormal SerRS dimerization, which suggests the impairment of total protein synthesis and induction of eIF2α phosphorylation.
Interpretation
Our findings suggest the heterozygous SerRS variants identified represent a novel cause for autosomal dominant CMT. Mutant SerRS proteins are known to impact various molecular and cellular functions. Our findings provide significant advances on the current understanding of the molecular mechanisms associated with ARS‐related CMT. ANN NEUROL 2023;93:244–256
Full text
Available for:
BFBNIB, FZAB, GIS, IJS, KILJ, NLZOH, NUK, OILJ, SAZU, SBCE, SBMB, UL, UM, UPUK
Soaring cases of coronavirus disease (COVID-19) are pummeling the global health system. Overwhelmed health facilities have endeavored to mitigate the pandemic, but mortality of COVID-19 continues to ...increase. Here, we present a mortality risk prediction model for COVID-19 (MRPMC) that uses patients' clinical data on admission to stratify patients by mortality risk, which enables prediction of physiological deterioration and death up to 20 days in advance. This ensemble model is built using four machine learning methods including Logistic Regression, Support Vector Machine, Gradient Boosted Decision Tree, and Neural Network. We validate MRPMC in an internal validation cohort and two external validation cohorts, where it achieves an AUC of 0.9621 (95% CI: 0.9464-0.9778), 0.9760 (0.9613-0.9906), and 0.9246 (0.8763-0.9729), respectively. This model enables expeditious and accurate mortality risk stratification of patients with COVID-19, and potentially facilitates more responsive health systems that are conducive to high risk COVID-19 patients.
During embryogenesis, the liver is the site of hepatogenesis and hematopoiesis and contains many cell lineages derived from the endoderm and mesoderm. However, the characteristics and developmental ...programs of many of these cell lineages remain unclear, especially in humans. Here, we performed single-cell RNA sequencing of whole human and mouse fetal livers throughout development. We identified four cell lineage families of endoderm-derived, erythroid, non-erythroid hematopoietic, and mesoderm-derived non-hematopoietic cells, and defined the developmental pathways of the major cell lineage families. In both humans and mice, we identified novel markers of hepatic lineages and an ID3
subpopulation of hepatoblasts as well as verified that hepatoblast differentiation follows the "default-directed" model. Additionally, we found that human but not mouse fetal hepatocytes display heterogeneity associated with expression of metabolism-related genes. We described the developmental process of erythroid progenitor cells during human and mouse hematopoiesis. Moreover, despite the general conservation of cell differentiation programs between species, we observed different cell lineage compositions during hematopoiesis in the human and mouse fetal livers. Taken together, these results reveal the dynamic cell landscape of fetal liver development and illustrate the similarities and differences in liver development between species, providing an extensive resource for inducing various liver cell lineages in vitro.
Full text
Available for:
EMUNI, FIS, FZAB, GEOZS, GIS, IJS, IMTLJ, KILJ, KISLJ, MFDPS, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, SBMB, SBNM, UKNU, UL, UM, UPUK, VKSCE, ZAGLJ
Aging is an important risk factor for cardiovascular diseases, and aging‐related cardiac dysfunction serves as a major determinant of morbidity and mortality in elderly populations. Our previous ...study has identified fibronectin type III domain‐containing 5 (FNDC5) and its cleaved form, irisin, as the cardioprotectant against doxorubicin‐induced cardiomyopathy. Herein, aging or matched young mice were overexpressed with FNDC5 by adeno‐associated virus serotype 9 (AAV9) vectors, or subcutaneously infused with irisin to uncover the role of FNDC5 in aging‐related cardiac dysfunction. To verify the involvement of nucleotide‐binding oligomerization domain‐like receptor with a pyrin domain 3 (NLRP3) and AMP‐activated protein kinase α (AMPKα), Nlrp3 or Ampkα2 global knockout mice were used. Besides, young mice were injected with AAV9‐FNDC5 and maintained for 12 months to determine the preventive effect of FNDC5. Moreover, neonatal rat cardiomyocytes were stimulated with tumor necrosis factor‐α (TNF‐α) to examine the role of FNDC5 in vitro. We found that FNDC5 was downregulated in aging hearts. Cardiac‐specific overexpression of FNDC5 or irisin infusion significantly suppressed NLRP3 inflammasome and cardiac inflammation, thereby attenuating aging‐related cardiac remodeling and dysfunction. In addition, irisin treatment also inhibited cellular senescence in TNF‐α‐stimulated cardiomyocytes in vitro. Mechanistically, FNDC5 activated AMPKα through blocking the lysosomal degradation of glucagon‐like peptide‐1 receptor. More importantly, FNDC5 gene transfer in early life could delay the onset of cardiac dysfunction during aging process. We prove that FNDC5 improves aging‐related cardiac dysfunction by activating AMPKα, and it might be a promising therapeutic target to support cardiovascular health in elderly populations.
FNDC5 is downregulated in aging hearts, and cardiac‐specific overexpression of FNDC5 or irisin infusion attenuates aging‐related inflammation, cardiac remodeling, and dysfunction. Mechanistically, FNDC5 activates AMPKα through blocking the lysosomal degradation of GLP‐1R.
Full text
Available for:
DOBA, FZAB, GIS, IJS, IZUM, KILJ, NLZOH, NUK, OILJ, PILJ, PNG, SAZU, SBCE, SBMB, UILJ, UKNU, UL, UM, UPUK
PDF
